INTRODUCTION: Transgenic rats with inducible expression of the mouse Ren2 renin gene [strain name: TGR(Cyp1a1Ren2)] allow induction of various degrees of ANG II-dependent hypertension. Dietary administration of the aryl hydrocarbon indole-3-carbinol (I3C) at a dose of 0.15% induces a slowly developing form of ANG II-dependent hypertension, whereas dietary administration of a higher dose (0.3%) of I3C results in the development of ANG II-dependent malignant hypertension. Cessation of administration of 0.15% I3C results in the normalization of blood pressure, indicating the reversibility of hypertension induced by this dose of I3C. The present study was performed to determine if ANG II-dependent malignant hypertension is similarly reversible following cessation of dietary administration of 0.3% I3C. METHODS: Cyp1a1-Ren2 rats (n = 6) were fed a normal diet containing 0.3% I3C for 11 days to induce malignant hypertension. RESULTS: Cyp1a1-Ren2 rats induced with I3C exhibited pronounced increases in systolic blood pressure (SBP) (132 +/- 3-229 +/- 11 mm Hg, P < 0.001) and marked decreases in body weight (303 +/- 4-222 +/- 2 g, P < 0.001). When I3C administration was terminated, SBP decreased to 167 +/- 4 mm Hg (P < 0.01) and body weight increased to normal levels (309 +/- 2 g, P < 0.01) within 12 days. However, SBP remained significantly elevated (172 +/- 1 mm Hg, P < 0.01) for up to 3 weeks after termination of dietary administration of 0.3% I3C. In addition, the magnitude of the blood pressure response to intravenous bolus administration of 50 ng of ANG II (50 microL in volume) 3 weeks after cessation of dietary I3C administration was substantially higher than that observed in normotensive control rats (134 +/- 1 mm Hg, n = 6) not previously induced with 0.3% I3C (53 +/- 2 versus 38 +/- 3 mm Hg, P < 0.05). CONCLUSIONS: The present findings demonstrate that transient induction of ANG II-dependent malignant hypertension results in prolonged elevations of arterial blood pressure and marked augmentation of the magnitude of the pressor response to ANG II in Cyp1a1-Ren2 transgenic rats.
INTRODUCTION:Transgenicrats with inducible expression of the mouseRen2renin gene [strain name: TGR(Cyp1a1Ren2)] allow induction of various degrees of ANG II-dependent hypertension. Dietary administration of the aryl hydrocarbon indole-3-carbinol (I3C) at a dose of 0.15% induces a slowly developing form of ANG II-dependent hypertension, whereas dietary administration of a higher dose (0.3%) of I3C results in the development of ANG II-dependent malignant hypertension. Cessation of administration of 0.15% I3C results in the normalization of blood pressure, indicating the reversibility of hypertension induced by this dose of I3C. The present study was performed to determine if ANG II-dependent malignant hypertension is similarly reversible following cessation of dietary administration of 0.3% I3C. METHODS:Cyp1a1-Ren2rats (n = 6) were fed a normal diet containing 0.3% I3C for 11 days to induce malignant hypertension. RESULTS:Cyp1a1-Ren2rats induced with I3C exhibited pronounced increases in systolic blood pressure (SBP) (132 +/- 3-229 +/- 11 mm Hg, P < 0.001) and marked decreases in body weight (303 +/- 4-222 +/- 2 g, P < 0.001). When I3C administration was terminated, SBP decreased to 167 +/- 4 mm Hg (P < 0.01) and body weight increased to normal levels (309 +/- 2 g, P < 0.01) within 12 days. However, SBP remained significantly elevated (172 +/- 1 mm Hg, P < 0.01) for up to 3 weeks after termination of dietary administration of 0.3% I3C. In addition, the magnitude of the blood pressure response to intravenous bolus administration of 50 ng of ANG II (50 microL in volume) 3 weeks after cessation of dietary I3C administration was substantially higher than that observed in normotensive control rats (134 +/- 1 mm Hg, n = 6) not previously induced with 0.3% I3C (53 +/- 2 versus 38 +/- 3 mm Hg, P < 0.05). CONCLUSIONS: The present findings demonstrate that transient induction of ANG II-dependent malignant hypertension results in prolonged elevations of arterial blood pressure and marked augmentation of the magnitude of the pressor response to ANG II in Cyp1a1-Ren2transgenicrats.
Authors: S Kantachuvesiri; S Fleming; J Peters; B Peters; G Brooker; A G Lammie; I McGrath; Y Kotelevtsev; J J Mullins Journal: J Biol Chem Date: 2001-07-11 Impact factor: 5.157
Authors: L M Forrester; C J Henderson; M J Glancey; D J Back; B K Park; S E Ball; N R Kitteringham; A W McLaren; J S Miles; P Skett Journal: Biochem J Date: 1992-01-15 Impact factor: 3.857
Authors: C E Whitworth; S Fleming; A D Cumming; J J Morton; N J Burns; B C Williams; J J Mullins Journal: Kidney Int Date: 1994-12 Impact factor: 10.612
Authors: P H Jellinck; P G Forkert; D S Riddick; A B Okey; J J Michnovicz; H L Bradlow Journal: Biochem Pharmacol Date: 1993-03-09 Impact factor: 5.858
Authors: C E Whitworth; S Fleming; Y Kotelevtsev; L Manson; G A Brooker; A D Cumming; J J Mullins Journal: Kidney Int Date: 1995-02 Impact factor: 10.612
Authors: Catherine J Leader; Barbara J Clark; Amber R Hannah; Ivan A Sammut; Gerard T Wilkins; Robert J Walker Journal: Comp Med Date: 2018-09-05 Impact factor: 0.982
Authors: Catherine J Leader; Mohammed Moharram; Sean Coffey; Ivan A Sammut; Gerard W Wilkins; Robert J Walker Journal: PLoS One Date: 2019-08-12 Impact factor: 3.240
Authors: Bart F J Heijnen; Jelly Nelissen; Helma van Essen; Gregorio E Fazzi; Jan W Cohen Tervaert; Carine J Peutz-Kootstra; John J Mullins; Casper G Schalkwijk; Ben J A Janssen; Harry A J Struijker-Boudier Journal: PLoS One Date: 2013-02-28 Impact factor: 3.240